Preparing Children for Invasive Medical Cancer Treatment with "My Logbook": Preliminary Results of a Pilot Study

Liesa J Weiler-Wichtl1,2, Verena Fohn-Erhold3, Verena Rosenmayr3

  • 1Department of Paediatrics and Adolescent Medicine, General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. liesa.weiler@meduniwien.ac.at.

Insights

New psychosocial tools significantly improve health literacy and emotional well-being in pediatric cancer patients undergoing treatment. These evidence-based interventions (EBIs) help reduce negative emotions and empower young patients.

Area of Science:

  • Pediatric Oncology
  • Psychosocial Care
  • Health Psychology

Background:

  • Pediatric cancer imposes significant medical, psychological, and socioeconomic burdens on young patients and their families.
  • Effective psychosocial care is crucial to mitigate adverse emotional impacts and provide adequate information during cancer treatment.
  • Evidence-based interventions (EBIs) are essential for comprehensive care in pediatric oncology.

Purpose of the Study:

  • To evaluate the effectiveness of novel, cancer-specific psychosocial tools developed within the "My Logbook" quality improvement project.
  • To assess the impact of these tools on pediatric cancer patients' health literacy and emotional well-being.
  • To explore the potential of patient-centered, creative interventions in pediatric oncology.

Main Methods:

  • Utilized four cancer-specific psychosocial tools designed for surgery, chemotherapy, radiotherapy, and stem cell transplantation preparation.
  • Employed self and proxy ratings to measure patients' subjective knowledge and emotional state before and after intervention sessions.
  • Applied creative and developmentally adapted methodologies, including psychoeducation, crafting, and games.

Main Results:

  • Interventions significantly enhanced patient health literacy (V=120.5, p<.001, r=0.33).
  • Patient well-being improved, indicated by a significant increase in positive emotions (slope=0.121, p=.016) and a decrease in negative emotions (slope=-0.350, p<.001).
  • Neutral emotions also showed a significant decrease (slope=-0.202, p=.002), suggesting a shift towards more positive emotional states.

Conclusions:

  • Patient-centered psychosocial interventions effectively improve health literacy and emotional well-being in pediatric cancer patients.
  • These findings support the development and implementation of standardized psychosocial care guidelines in pediatric oncology.
  • The ultimate goal is to enhance the quality of life for all pediatric cancer patients through education and empowerment.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...